Skip to main content

Table 5 PRKAA1 Polymorphisms with clinical outcome of patients with NGCA

From: Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer

Genotype

All patients

NGCA

HR (95% CI)

p-Value

HR (95% CI)

p-Value

HR (95% CI)a

p-Value

HR (95% CI)b

p-Value

rs10074991

 AA

Reference

 

Reference

 

Reference

 

Reference

 

 AG

1.16(0.87,1.55)

0.300

1.62(1.10,2.38)

0.015

1.63(1.10,2.41)

0.015

1.80(1.21,2.67)

0.004

 GG

1.15(0.83,1.59)

0.401

1.64(1.08,2.49)

0.020

1.71(1.12,2.60)

0.012

1.75(1.13,2.70)

0.012

 AG/GG

1.16(0.88,1.52)

0.290

1.62(1.12,2.35)

0.011

1.66(1.14,2.41)

0.008

1.78(1.21,2.61)

0.003

rs13361707

 TT

Reference

 

Reference

 

Reference

 

Reference

 

 TC

1.18(0.89,1.57)

0.253

1.67(1.13,2.47)

0.010

1.68(1.13,2.50)

0.010

1.85(1.24,2.77)

0.003

 CC

1.16(0.84,1.61)

0.364

1.68(1.10,2.56)

0.016

1.76(1.15,2.68)

0.009

1.79(1.16,2.78)

0.009

 TC/CC

1.18(0.90,1.54)

0.246

1.67(1.15,2.44)

0.007

1.71(1.17,2.50)

0.006

1.83(1.24,2.70)

0.002

rs154268

 TT

Reference

 

Reference

     

 TC

1.08(0.85,1.36)

0.525

1.18(0.90,1.56)

0.242

    

 CC

1.23(0.78,1.94)

0.367

1.29(0.78,2.12)

0.322

    

 TC/CC

1.10(0.88,1.17)

0.405

1.20(0.92,1.56)

0.183

    

rs6882903

 CC

Reference

 

Reference

     

 CA

0.97(0.76,1.24)

0.796

1.12(0.84,1.48)

0.443

    

 AA

1.48(0.89,2.47)

0.130

1.56(0.90,2.72)

0.113

    

 CA/AA

1.02(0.81,1.29)

0.869

1.17(0.89,1.53)

0.252

    

rs3805490

 TT

Reference

 

Reference

     

 TA

1.03(0.82,1.30)

0.807

1.07(0.81,1.41)

0.626

    

 AA

0.82(0.51,1.31)

0.404

0.97(0.55,1.68)

0.898

    

 TA/AA

0.99(0.80,1.24)

0.953

1.06(0.81,1.37)

0.691

    

rs461404

 AA

Reference

 

Reference

     

 GA

1.08(0.86,1.37)

0.506

1.19(0.90,1.56)

0.352

    

 GG

1.25(0.80,1.94)

0.333

1.31(0.80,2.13)

0.228

    

 GA/GG

1.11(0.89,1.38)

0.379

1.21(0.93,1.57)

0.165